Home › Trial NCT07505849
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma
- Trial IDNCT07505849
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorKeshuZhou
- Enrollment100
- Start date2026-03-23
- ConditionsFollicular Lymphomas
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.